Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Randomized Prospective Study of Instrumented Posterior Lumbar Interbody Fusion: Autologous Iliac Crest Bone Graft vs. Inductos
2005-005766-36Phase 4Completed
- Sponsor
- Sofamor Danek
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of dibotermin alfa in lumbosacral disc disease, lumbar instability and lumbar spondylolisthesis (2 arms), sponsored by Sofamor Danek. Primary endpoint: Two-year fusion outcome. Started Oct 2006; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
lumbosacral disc diseaselumbar instabilitylumbar spondylolisthesis
Beyond the preview
Go deeper on 2005-005766-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005766-36.